基本信息
views: 282
Career Trajectory
Bio
He has 45 years of experience in toxicology and risk assessment, primarily in developing and applying physiologically based pharmacokinetic and biologically based pharmacodynamic models in quantitative safety assessments. He has worked in federal government, private industry and academia.
Mel works with sponsors to evaluate modes of action of chemicals on the basis of time and dose-related changes in gene expression in cells and tissues and apply new alternative methodologies in human health risk assessment.
Mel works with sponsors to evaluate modes of action of chemicals on the basis of time and dose-related changes in gene expression in cells and tissues and apply new alternative methodologies in human health risk assessment.
Research Interests
Papers共 605 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Zhiqiang Jiang, Lili Yang, Qinxin Liu,Meiyue Qiu, Yu Chen, Fei Qu,M.James C. Crabbe,Hongbing Wang,Melvin E. Andersen,Yuxin Zheng,Weidong Qu
Water Research (2024): 122008-122008
Lili Yang,Zhiqiang Jiang,Lan Yang,Weiwei Zheng, Yu Chen, Fei Qu,M James C Crabbe,Yubin Zhang,Melvin E Andersen,Yuxin Zheng,Weidong Qu
TOXICOLOGY LETTERS (2024): 1373325-1373325
Toxicology and Applied Pharmacology (2024): 116956-116956
Toxicological sciences : an official journal of the Society of Toxicologyno. 2 (2023): 170-186
Toxicological sciences : an official journal of the Society of Toxicologyno. 1 (2023): 1-17
Frontiers in Pharmacology (2023)
Load More
Author Statistics
#Papers: 598
#Citation: 28101
H-Index: 86
G-Index: 86
Sociability: 8
Diversity: 3
Activity: 56
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn